<?xml version="1.0" encoding="UTF-8"?>
<ref id="B329-viruses-12-00110">
 <label>329.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sonntag</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Hahn</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Bertzbach</surname>
    <given-names>L.D.</given-names>
   </name>
   <name>
    <surname>Seyler</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wangen</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>MÃ¼ller</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Tannig</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Grau</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Baumann</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zent</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model</article-title>
  <source>Antivir. Res.</source>
  <year>2019</year>
  <volume>161</volume>
  <fpage>63</fpage>
  <lpage>69</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.11.008</pub-id>
  <?supplied-pmid 30452929?>
  <pub-id pub-id-type="pmid">30452929</pub-id>
 </element-citation>
</ref>
